FDA Inspection
RX South DBA RX3 Compounding Pharmacy LLCRX South DBA RX3 Compounding Pharmacy LLC – FDA Inspection, Feb 21, 2014
Record Details
This FDA Inspection record concerns RX South DBA RX3 Compounding Pharmacy LLC, with an inspection on February 21, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- February 21, 2014
- Product Type
- Drugs
View Company Profile
ID · 66cbcaf0-555c-4539-8aa2-b488424fa23c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 865144
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
11- 21 CFR 211.42(c)(10)(iii)Air Supply
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.28(a)Clothing appropriate for duties performed
- 21 CFR 211.84(d)(3)Testing Containers & Closures Conformity with Specs
- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.113(b)Validation lacking for sterile drug products
- 21 CFR 211.68(a)Calibration/Inspection/Checking not done
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.22(a)Contract drug products--lack of responsibility
Showing 10 of 11 citations.
Full citation text and observation details available on the Dashboard.
Other FDA inspections of RX South DBA RX3 Compounding Pharmacy LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 14, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for RX South DBA RX3 Compounding Pharmacy LLC
- FDA Inspection 810869 - 2012-12-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.